Kelli Kennedy, FNP

Kelli Kennedy practices at Vita, Vascular Interventional of Thomasville Associates in Thomasville, Georgia.

Kelli Kennedy's NPI, 1710567854, was assigned on April 13, 2021. Kelli Kennedy holds Georgia license RN244596.

Kelli Kennedy's primary practice is Vita, Vascular Interventional of Thomasville Associates, at 900 Gordon Ave, Thomasville, GA 31792 in Thomas County. The practice phone is (229) 227-5104.

Kelli Kennedy's primary practice is Vita, Vascular Interventional of Thomasville Associates in Thomasville, Georgia. Kelli Kennedy is also affiliated with Archbold Memorial. The medical group on file is VITA Vascular Interventional of Thomasville Associates. Dmand AI also links Kelli Kennedy to 1 more hospital, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kelli Kennedy practices, 5 sites in all. Vendor and product names are available with a free account.

Family is Kelli Kennedy's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Kelli Kennedy is licensed in Georgia.

Dmand AI lists acute skin infection, arthritis and muscle pain, fibromyalgia, and limb pain among the conditions Kelli Kennedy treats.

CMS data shows 128 Medicare services from Kelli Kennedy across 4 procedure codes in 2024, for 115 Medicare patients. Medicare paid $10,726 for them.

CMS counts 115 Medicare patients who saw Kelli Kennedy in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kelli Kennedy's median patient age at 72, with 57% women.

In 2024, Kelli Kennedy wrote 60 Medicare Part D claims for 25 patients. 62% of them were for generic drugs. CMS names the drug for 35 of them, across 2 drugs with 11 or more claims each, at $10,772 in total drug cost.

Kelli Kennedy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 20 general payments to Kelli Kennedy from 9 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Penumbra, Inc. paid the most, $362.